• ##navigation.register##
  • ##navigation.login##
    • en
    • uz
    • ru
  • en
  • uz
  • ru
##navigation.register## ##navigation.login##
  • Joriy
  • ##navigation.archives##
    • ##about.aboutContext##
    • ##about.submissions##
    • ##common.editorialMasthead##
    • ##manager.setup.privacyStatement##
    • ##about.contact##
Joriy ##navigation.archives##
##about.aboutContext## ##about.submissions## ##common.editorialMasthead## ##manager.setup.privacyStatement## ##about.contact##
  1. ##common.homepageNavigationLabel##
  2. ##common.search##

##common.search##

##search.advancedFilters##
##search.dateFrom##
##search.dateTo##

##search.searchResults##

##search.searchResults.foundSingle##
  • OPTIMIZATION OF COMPREHENSIVE TREATMENT OF LICHEN RUBER PLANUS: CLINICAL-IMMUNOLOGICAL STUDY

    Tashkenbaeva U.A.##common.commaListSeparator##Safarov Kh.Kh.

    Objective: to study the clinical and immunological characteristics of various forms of LC and to evaluate the effectiveness of combined therapy using narrow-band UVB therapy (311 nm), excimer laser (308 nm), and topical tacrolimus. Materials and methods: The prospective study included 118 patients with verified CPL, randomized into 4 groups. The 1st group (n=28) received standard therapy (topic corticosteroids, antihistamines, vitamins), the 2nd group (n=29) received standard therapy + UVB-311, the 3rd group (n=30) received standard therapy + UVB-311 + excimer laser, the 4th group (n=31) received standard therapy + UVB-311 + excimer laser + tacropic cream. The effectiveness was assessed by the dynamics of LPASI, REU, VAS indices, cytokine levels (IL-6, IL-1β, IL-10), dermatoscopic picture, and quality of life (HADS). Results: The highest clinical effectiveness was noted in the 4th group: a decrease in the LPASI index by 85.1% (p<0.001), the REU index by 0.64±0.23 (p<0.01), and the intensity of itching by VAS by 82%. In this same group, normalization of the cytokine profile (IL-6, IL-1β, IL-10) and maximum improvement of the quality of life (reduction of anxiety and depression according to HADS by 77.2% and 87.8%, respectively) were recorded. Dermatoscopic signs of activity (Wickham's network, vascular patterns) regressed most significantly in the combined therapy groups. Conclusions: Combined CPL therapy, including UVB-311, 308 nm excimer laser, and topical tacrolimus, is a highly effective pathogenetically justified approach that provides not only clinical improvement but also normalization of immunological indicators and improvement of patients' quality of life.

    22-26
    09-01-2026
    Davomini o‘qing
##navigation.items##

Ma'lumot

  • ##navigation.infoForReaders##
  • Mualliflar uchun
  • Kutubxonachilar uchun

So'nggi nashrlar

  • Atom logotipi
  • RSS2 logotipi
  • RSS1 logotipi
TNMU Publishing

Biz tibbiyotning rivojlanishini tezlashtirish va jamiyat salomatligini yaxshilash uchun tadqiqotchilar, bilim va texnologiyalarni birlashtiramiz.

 

Navigatsiya

Bosh sahifa
Jurnallar
Konferensiyalar
Mualliflar
Taqrizchilar
Nashriyot xizmatlari

Madad

Ijodkor qoidalari
Nashr axloqi
Biz haqimizda
Savol-javob
Qayta aloqa

Kontaktlar

 
O‘zbekiston, Toshkent,,
Olmazor tumani, Shifokorlar ko‘chasi, 21-uy
 
(+998) 91 164 24 40
 
publishing@tnmu.uz
© Copyright 2026 TNMU Publishing All Rights Reserved | Developed by in Science | Site create by in Designer
##user.login##
Central Asian Journal of Medicine
##user.login##
* ##common.required##
* ##common.required##
##user.login.forgotPassword##
##user.login.rememberUsernameAndPassword##
##user.login.registerNewAccount##